Cannabis Medical Marijuana

In a milestone event for the cannabis industry in Europe and the UK, on Wednesday, cannabis shares were traded on the London Stock Exchange (LSE) for the first time.

It came as MGC Pharmaceuticals was listed on the LSE after the company successfully raised £6.5 million (€7.41 million) through an oversubscribed funding drive which saw the company decline millions in investment funding.

The company’s managing director, Roby Zomer, said it is “proud to make history as the first medical cannabis company on [the] historic exchange”.

MGC Pharma is an Australian-listed company. Its two flagship phytocannabinoid-derived medicines, CannEpil, and CogniCann are designed to treat refractory epilepsy, and improve dementia and Alzheimer’s patients quality of life.

The company has a growing patient base in Australia, the UK, Brazil and Ireland and has a global distribution format via its network of commercial partners, meaning it poised to supply the global market. 

Europe’s medical cannabis market is believed to have massive potential. 

In 2020, Marijuana Business Daily estimated that the European legal medical cannabis market one day eclipse North America’s. In the USA, the legal marijuana industry was estimated to have a value of $13.6 billion (€11.23 billion) in 2019. 

Malta is an EU leader for its cannabis law. In 2018, it enacted the Production of Cannabis for Medicinal and Research Purposes Act, which legalised the production of cannabis for medical purposes.

The Body Shop’s fair-trade suppliers might be left in limbo after collapse of UK company

February 19, 2024
by Anthea Cachia

The company is known of its standards of ethical, fair trade and cruelty free products

Ever wonder how many videos are on YouTube? Researchers reveal it’s a whopping 14 billion

February 10, 2024
by Robert Fenech

The way YouTube is used makes it most aptly described as infrastructure, say researchers

European Parliament to establish TikTok presence despite app’s ban on corporate phones

February 7, 2024
by Anthea Cachia

The Parliament is adopting this approach to fight disinformation and get the message across, while retaining cyber security